JME

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Medical Ethics 2005;31:736-738; doi:10.1136/jme.2005.012013
Copyright © 2005 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lynöe, N
Right arrow Articles by Hoeyer, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lynöe, N
Right arrow Articles by Hoeyer, K

RESEARCH ETHICS

Quantitative aspects of informed consent: considering the dose response curve when estimating quantity of information

N Lynöe1, K Hoeyer2

1 Centre for Bioethics, LIME, Karolinska Institutet, Stockholm, Sweden
2 Department of Health Services Research, Institute of Public Health, University of Copenhagen, Denmark

Correspondence to:
Professor N Lynöe
Centre for Bioethics, LIME, Karolinska Institutet, Stockholm, Sweden; niels.lynoe{at}lime.ki.se Information is usually supposed to be a prerequisite for people making decisions on whether or not to participate in a clinical trial. Previously conducted studies and research ethics scandals indicate that participants have sometimes lacked important pieces of information. Over the past few decades the quantity of information believed to be adequate has increased significantly, and in some instances a new maxim seems to be in place: the more information, the better the ethics in terms of respecting a participant’s autonomy. The authors hypothesise that the dose-response curve from pharmacology or toxicology serves as a model to illustrate that a large amount of written information does not equal optimality. Using the curve as a pedagogical analogy when teaching ethics to students in clinical sciences, and also in engaging in dialogue with research institutions, may promote reflection on how to adjust information in relation to the preferences of individual participants, thereby transgressing the maxim that more information means better ethics.


Keywords: clinical research; informed consent; participants’ perceptions; pedagogical model; information




This article has been cited by other articles:


Home page
J. Med. EthicsHome page
W Osterlie, M Solbjor, J-A Skolbekken, S Hofvind, A R Saetnan, and S Forsmo
Challenges of informed choice in organised screening
J. Med. Ethics, September 1, 2008; 34(9): e5 - e5.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.